183 related articles for article (PubMed ID: 24867421)
1. EphA2 targeting pegylated nanocarrier drug delivery system for treatment of lung cancer.
Patel AR; Chougule M; Singh M
Pharm Res; 2014 Oct; 31(10):2796-809. PubMed ID: 24867421
[TBL] [Abstract][Full Text] [Related]
2. Combination Approach of YSA Peptide Anchored Docetaxel Stealth Liposomes with Oral Antifibrotic Agent for the Treatment of Lung Cancer.
Patel K; Doddapaneni R; Sekar V; Chowdhury N; Singh M
Mol Pharm; 2016 Jun; 13(6):2049-58. PubMed ID: 27070720
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Spray BIO-Max DIM-P in Dogs for Oral Bioavailability and in Nu/nu Mice Bearing Orthotopic/Metastatic Lung Tumor Models for Anticancer Activity.
Patel AR; Godugu C; Wilson H; Safe S; Singh M
Pharm Res; 2015 Jul; 32(7):2292-300. PubMed ID: 25576245
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of self-emulsified DIM-14 in dogs for oral bioavailability and in Nu/nu mice bearing stem cell lung tumor models for anticancer activity.
Patel AR; Doddapaneni R; Andey T; Wilson H; Safe S; Singh M
J Control Release; 2015 Sep; 213():18-26. PubMed ID: 26079185
[TBL] [Abstract][Full Text] [Related]
5. Dual targeting for metastatic breast cancer and tumor neovasculature by EphA2-mediated nanocarriers.
Guo Z; He B; Yuan L; Dai W; Zhang H; Wang X; Wang J; Zhang X; Zhang Q
Int J Pharm; 2015 Sep; 493(1-2):380-9. PubMed ID: 26004003
[TBL] [Abstract][Full Text] [Related]
6. Multifunctional tumor-targeting nanocarriers based on hyaluronic acid-mediated and pH-sensitive properties for efficient delivery of docetaxel.
Song S; Chen F; Qi H; Li F; Xin T; Xu J; Ye T; Sheng N; Yang X; Pan W
Pharm Res; 2014 Apr; 31(4):1032-45. PubMed ID: 24154802
[TBL] [Abstract][Full Text] [Related]
7. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
[TBL] [Abstract][Full Text] [Related]
8. 1,1-Bis (3'-indolyl)-1-(p-substitutedphenyl)methane compounds inhibit lung cancer cell and tumor growth in a metastasis model.
Andey T; Patel A; Jackson T; Safe S; Singh M
Eur J Pharm Sci; 2013 Oct; 50(2):227-41. PubMed ID: 23892137
[TBL] [Abstract][Full Text] [Related]
9. Systemic delivery of nanoparticle formulation of novel tubulin inhibitor for treating metastatic melanoma.
Mundra V; Peng Y; Kumar V; Li W; Miller DD; Mahato RI
Drug Deliv Transl Res; 2015 Jun; 5(3):199-208. PubMed ID: 25924699
[TBL] [Abstract][Full Text] [Related]
10. New Folate-Grafted Chitosan Derivative To Improve Delivery of Paclitaxel-Loaded Solid Lipid Nanoparticles for Lung Tumor Therapy by Inhalation.
Rosière R; Van Woensel M; Gelbcke M; Mathieu V; Hecq J; Mathivet T; Vermeersch M; Van Antwerpen P; Amighi K; Wauthoz N
Mol Pharm; 2018 Mar; 15(3):899-910. PubMed ID: 29341619
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo evaluation of PEGylated nanoparticles of bendamustine for treatment of lung cancer.
Dubey P; Gidwani B; Pandey R; Shukla SS
Artif Cells Nanomed Biotechnol; 2016 Sep; 44(6):1491-7. PubMed ID: 26134925
[TBL] [Abstract][Full Text] [Related]
12. Enhanced in vivo antitumor efficacy of dual-functional peptide-modified docetaxel nanoparticles through tumor targeting and Hsp90 inhibition.
Jiang Y; Yang N; Zhang H; Sun B; Hou C; Ji C; Zheng J; Liu Y; Zuo P
J Control Release; 2016 Jan; 221():26-36. PubMed ID: 26643616
[TBL] [Abstract][Full Text] [Related]
13. Biodegradable double-targeted PTX-mPEG-PLGA nanoparticles for ultrasound contrast enhanced imaging and antitumor therapy in vitro.
Ma J; Shen M; Xu CS; Sun Y; Duan YR; Du LF
Oncotarget; 2016 Nov; 7(48):80008-80018. PubMed ID: 27835907
[TBL] [Abstract][Full Text] [Related]
14. Docetaxel immunonanocarriers as targeted delivery systems for HER 2-positive tumor cells: preparation, characterization, and cytotoxicity studies.
Koopaei MN; Dinarvand R; Amini M; Rabbani H; Emami S; Ostad SN; Atyabi F
Int J Nanomedicine; 2011; 6():1903-12. PubMed ID: 21931485
[TBL] [Abstract][Full Text] [Related]
15. Antitumor efficiency of D-alpha-tocopheryl polyethylene glycol 1000 succinate-b-poly(epsilon-caprolactone-ran-lactide) nanoparticle-based delivery of docetaxel in mice bearing cervical cancer.
Wang Z; Zeng X; Ma Y; Liu J; Tang X; Gao Y; Liu K; Zhang J; Ming P; Huang L; Mei L
J Biomed Nanotechnol; 2014 Aug; 10(8):1509-19. PubMed ID: 25016651
[TBL] [Abstract][Full Text] [Related]
16. Theranostic tumor homing nanocarriers for the treatment of lung cancer.
Patel AR; Chougule MB; Lim E; Francis KP; Safe S; Singh M
Nanomedicine; 2014 Jul; 10(5):1053-63. PubMed ID: 24355163
[TBL] [Abstract][Full Text] [Related]
17. Actively-targeted LTVSPWY peptide-modified magnetic nanoparticles for tumor imaging.
Jie LY; Cai LL; Wang LJ; Ying XY; Yu RS; Zhang MM; Du YZ
Int J Nanomedicine; 2012; 7():3981-9. PubMed ID: 22866005
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of aerosolized celecoxib encapsulated nanostructured lipid carrier in non-small cell lung cancer in combination with docetaxel.
Patel AR; Chougule MB; I T; Patlolla R; Wang G; Singh M
Pharm Res; 2013 May; 30(5):1435-46. PubMed ID: 23361589
[TBL] [Abstract][Full Text] [Related]
19. PEGylated self-assembled enzyme-responsive nanoparticles for effective targeted therapy against lung tumors.
Guo F; Wu J; Wu W; Huang D; Yan Q; Yang Q; Gao Y; Yang G
J Nanobiotechnology; 2018 Jul; 16(1):57. PubMed ID: 30012166
[TBL] [Abstract][Full Text] [Related]
20. Effect of octreotide surface density on receptor-mediated endocytosis in vitro and anticancer efficacy of modified nanocarrier in vivo after optimization.
Su Z; Shi Y; Xiao Y; Sun M; Ping Q; Zong L; Li S; Niu J; Huang A; You W; Chen Y; Chen X; Fei J; Tian J
Int J Pharm; 2013 Apr; 447(1-2):281-92. PubMed ID: 23396258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
